Maximum Dose of QuilliChew for a 9-Year-Old
The maximum recommended daily dose of QuilliChew ER for a 9-year-old is 60 mg once daily, as daily doses above 60 mg have not been studied and are not recommended. 1
FDA-Approved Dosing Parameters
The FDA label for QuilliChew ER is explicit and unambiguous about dosing limits 1:
- Starting dose: 20 mg once daily in the morning
- Titration: Weekly increments of 10 mg, 15 mg, or 20 mg based on efficacy and tolerability
- Maximum dose: 60 mg daily (doses above this have not been studied and are not recommended)
- Age indication: Approved for patients 6 years and above
Clinical Context and Supporting Evidence
While older methylphenidate guidelines reference a general maximum of 60 mg/day for immediate-release formulations 2, QuilliChew ER's specific formulation and extended-release mechanism require adherence to its product-specific maximum of 60 mg daily 1.
Weight-Based Considerations
For a typical 9-year-old (average weight ~30 kg), the 60 mg maximum dose translates to approximately 2 mg/kg/day. Historical guidelines suggest:
- Children weighing less than 25 kg generally should not receive single doses greater than 15 mg of immediate-release methylphenidate 2
- However, QuilliChew ER is a once-daily extended-release formulation with different pharmacokinetics than immediate-release products 1
Real-World Dosing Patterns
A 2018 open-label dose-optimization study of QuilliChew ER in children aged 6-12 years found 3:
- Mean final optimized dose ranged from 40.0 mg/day (ages 6-8) to 44.8 mg/day (ages 11-12)
- Final optimized doses ranged from 20-60 mg/day across all participants
- Progressive improvement in ADHD symptoms occurred throughout titration
Important Clinical Caveats
Do not exceed 60 mg daily for the following reasons:
Lack of safety and efficacy data: Doses above 60 mg have not been studied in clinical trials for QuilliChew ER 1
Diminishing returns: Recent meta-analyses demonstrate a ceiling effect for methylphenidate efficacy, where dose escalation beyond licensed ranges offers minimal additional benefit while increasing adverse events 4
Increased adverse event risk: The risk of discontinuation due to adverse events (sleep problems, decreased appetite, irritability) increases substantially at higher doses 4, 3
Product-specific limitations: QuilliChew ER cannot be substituted milligram-per-milligram with other methylphenidate products due to different base compositions and pharmacokinetic profiles 1
Titration Algorithm
For a 9-year-old starting QuilliChew ER:
- Week 1: Start 20 mg once daily in the morning
- Week 2: Increase to 30 mg if inadequate response and good tolerability
- Week 3: Increase to 40 mg if needed
- Week 4: Increase to 50 mg if needed
- Week 5: Increase to 60 mg (maximum) only if clearly inadequate response at 50 mg and excellent tolerability
Stop titration when: Symptoms are adequately controlled with acceptable side effects, or when the maximum dose of 60 mg is reached 1.
When Maximum Dose Is Insufficient
If a 9-year-old does not respond adequately to 60 mg of QuilliChew ER after appropriate titration (typically 4-6 weeks), do not exceed 60 mg. Instead 2, 1:
- Consider switching to an alternative methylphenidate formulation
- Consider switching to an alternative stimulant (amphetamine-based)
- Reassess the diagnosis and evaluate for comorbid conditions
- Consider adding behavioral interventions or psychosocial treatments
- Evaluate medication adherence and timing of administration
The principle "more is not necessarily better" applies—if the top recommended dose does not help, a change in drug or environmental intervention may be required rather than exceeding the maximum dose 2.